A PYMNTS Company

US: Judge dismisses Torrent antitrust claim over Abilify

By  |  May 8, 2016

A federal judge has dismissed an antitrust claim filed by Torrent Pharmaceuticals Ltd against Japanese drug maker Otsuka Pharmaceuticals Co Ltd over Otsuka’s attempts to enforce patents on its antipsychotic drug Abilify.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    US District Judge Jerome Simandle in New Jersey ruled Wednesday that Torrent’s claim that it was being kept out of the Abilify market could not stand because it had, in fact, launched a generic version of the drug last year.

    Full Content: Reuters

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.